Chemical Compound
(-)-Epigallocatechin gallate
CAS Registry Number
989-51-5
Primary Record
(-)-Epigallocatechin gallate
- In stock
- 8,160 g
- Purity
- 99.5 %
- CAS
- 989-51-5
Compound Identifiers & Properties
- CAS
- 989-51-5
- PubChem CID
- 65064
- SMILES
- C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
- Canonical SMILES
- O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1
Names & Synonyms
- (-)-Epigallocatechin gallate
- EGCG
- Epigallocatechin gallate
- Tea catechin
- 989-51-5
- Teavigo
- Epigallocatechin 3-gallate
- Epigallocatechin-3-gallate
- EGCG cpd
- Catechin deriv.
- polyphenols
- Epigallocate
- Sunphenon
- (-)-Epigallocatechin-3-o-gallate
- Epigallocic acid
- Teavigo;
- Teatannin II
- Epigallocatechingallate
- EGCG analogs
- Epigallocatechin-3-monogallate
- GTPs,Anagen
- 2kdh
- 3oob
- 4awm
- Green tea extract
- (-)-Epigallocatechol gallate
- L-Epigallocatechin gallate
- EGCG, Anagen
- epigallo-catechin gallate
- PF-EGCg 90
- Epigallocatechin-gallate
- (-)-epigallocatechin 3-gallate
- BQM438CTEL
- NVP-XAA 723
- UNII-BQM438CTEL
- -Epigallocatechingallate
- RefChem:5796
- Epigallocatcchin Gallate
- epigallocatechin-3-O-gallate
- Spectrum_000316
- SpecPlus_000277
- 3-O-Galloylepigallocatechin
- DTXSID1029889
- Spectrum2_000168
- Spectrum3_000244
- Spectrum4_001541
- Spectrum5_000102
- (-)-EGCG
- CCRIS 3729
- GlyTouCan:G31622WS
- Galloyl-L-epigallocatechol
- WMBWREPUVVBILR-WIYYLYMNSA-N
- EGCG [WHO-DD]
- (-)-epigallocatechin 3-O-gallate
- (-)-Epigallocatechin-3-gallate
- EPIGALOCATECHIN GALLATE
- D0E9DB
- D0U2BH
- DTXCID80567
- EGCG [MI]
- AC1L22IG
- AC1Q5X0Z
- CHEBI:4806
- CHEMBL297453
- (-)-Epigallocatechin gallat
- (-)-Epigallocatehin gallate
- NVP-XAA723
- C22H18O11
- MFCD00075940
- SCHEMBL35258
- BSPBio_001628
- epigallocatechin-gallate-(-)
- KBioGR_002002
- KBioSS_000796
- SPECTRUM210239
- cid_65064
- MLS000758300
- MLS001424000
- DivK1c_006373
- EPIGALLOCATECHIN 3-O-GALLATE
- Green tea polyphenols, Anagen
- SPBio_000035
- Epigallocatechin gallate(EGCG)
- Epigallocatechin monogallate, B
- GTPL7002
- MEGxp0_001166
- orb1304766
- 3-O-Galloyl-(-)-epigallocatechin
- Epigallocatechin gallate, Anagen
- SCHEMBL30014282
- ACon1_001054
- ERK5-6G16
- KBio1_001317
- KBio2_000796
- KBio2_003364
- KBio2_005932
- KBio3_001128
- AOB2839
- Epigallocatechol, 3-gallate, (-)-
- 2'-Fluoro-4'-methoxyacetophenone
- EGCG (Epigallocatechin gallate )
- EGCG solution, 20 mM in DMSO
- (-)-Epigallocatechin gallate (EGCG)
- (-)-EpigallocatechinGallateHydrate
- GLXC-04918
- HMS2051K21
- HMS3649E08
- (-)-Epigallocatechol 3-O-gallate
- CID65064
- G31622WS
- MSK40118
- ZINC3870412
- Tox21_201468
- Tox21_303457
- (-) EPIGALLOCATECHIN GALLATE
- (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate
- BBF-03974
- BDBM50070942
- CCG-38378
- CID:65064
- FR-109
- HY-13653R
- LMPK12030005
- s2250
- (-)-Epigallocatechin Gallate (Standard)
- AKOS015918182
- 3-O-(4-Hydroxybenzoyl)epigallocatechin
- ACN-035233
- CS-1258
- CS-O-01489
- DB12116
- DS-9030
- EBC-409044
- EBD2138593
- FE09970
- LS-2197
- NC00078
- SDCCGMLS-0066550.P001
- (-)-Epigallocatechin gallate, >=95%
- (-)-Epigallocatechin-3-gallate; EGCG
- (-)-Epigallocatechin-3-O-gallate CRS
- C22-H18-O11
- Epigallocatechin gallate analogs, Anagen
- KS-0000132O
- NCGC00164319-01
- NCGC00164319-02
- NCGC00164319-03
- NCGC00164319-04
- NCGC00164319-06
- NCGC00164319-07
- NCGC00164319-09
- NCGC00164319-10
- NCGC00257243-01
- NCGC00259019-01
- (-)-Epigallocatechin Gallate, food grade
- AC-34075
- AN-15867
- BP-30205
- CAS-989-51-5
- CPD000449288
- HY-13653
- K791
- SAM001247031
- SC-47284
- SID:53787947
- SMR000449288
- ST097428
- SY029068
- M01719
- AB0014381
- J134.058A
- A2600
- CS-0694875
- E0694
- N1874
- NS00015163
- SW197458-3
- (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
- [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate
- A10005
- C09731
- W-5069
- N-Benzyl-N'-ethyl-N-methyl-propane-1,3-diamine
- (-)-Epigallocatechin gallate, >=97.0% (HPLC)
- (-)-Epigallocatechin gallate, analytical standard
- [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate
- 989E515
- A845931
- C045651
- Epigallocatechin Gallate solution, 20 mM in DMSO
- Gallic acid, 3-ester with epigallocatechol, (-)-
- Q393339
- SR-01000759328
- SR-01000946601
- (-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS]
- (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate
- epigallocatechin-3-gallate solution, 20 mM in DMSO
- I14-7747
- Q-100914
- SR-01000759328-5
- SR-01000759328-6
- SR-01000946601-1
- (-)-EPIGALLOCATECHIN GALLATE (REFERENCE GRADE)
- BRD-K55591206-001-18-1
- BRD-K55591206-001-19-9
- BRD-K55591206-001-20-7
- (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT)
- (-)-Epigallocatechin Gallate solution, 20 mM in DMSO
- Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester
- Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester
- (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate
- ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE
- Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile
- (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea
- (-)-Epigallocatechin gallate, 98%, from Green Tea - 100MG 100mg
- (-)-Epigallocatechin Gallate, disposable screening library format
- Epigallocatechin gallate, primary pharmaceutical reference standard
- (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate)
- (2R)-2-(3,4,5-Trihydroxyphenyl)-3alpha-(galloyloxy)-5,7-dihydroxychroman
- (2R)-2alpha-(3,4,5-Trihydroxyphenyl)-3alpha-(galloyloxy)chroman-5,7-diol
- (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate)
- 2alpha-(3,4,5-Trihydroxyphenyl)-3alpha-(galloyloxy)chroman-5,7-diol
- ((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate
- (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate
- (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard
- (2R)-3alpha-(3,4,5-Trihydroxybenzoyloxy)-2alpha-(3,4,5-trihydroxyphenyl)chroman-5,7-diol
- (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate
- (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate
- [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate
- 2alpha-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-3alpha-(galloyloxy)-2H-1-benzopyran-5,7-diol
- 2alpha-(3,4,5-Trihydroxyphenyl)-3alpha-(3,4,5-trihydroxybenzoyloxy)chroman-5,7-diol
- 2alpha-(3,4,5-Trihydroxyphenyl)-3alpha-(galloyloxy)-3,4-dihydro-2H-1-benzopyran-5,7-diol
- 2alpha-(3,4,5-Trihydroxyphenyl)chroman-3alpha,5,7-triol 3-(3,4,5-trihydroxybenzoate)
- 3,4-Dihydro-2alpha-(3,4,5-trihydroxyphenyl)-3alpha-(galloyloxy)-2H-1-benzopyran-5,7-diol
- Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material
- ((2S,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl) 3,4,5-trihydroxybenzoate
- (-)-3,4,5-Trihydroxybenzoic acid [(2R)-3,4-dihydro-5,7-dihydroxy-2alpha-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran]-3alpha-yl ester
- (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate, (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate, EGCG
- (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate
- (-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE)
- (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT) [DSC]
- (2R)-2alpha-(3,4,5-Trihydroxyphenyl)-3alpha-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2H-1-benzopyran-5,7-diol
- (2R)-2alpha-(3,4,5-Trihydroxyphenyl)-3alpha-(3,4,5-trihydroxybenzoyloxy)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran
- (2R)-3,4-Dihydro-2alpha-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3alpha,5,7-triol 3-(3,4,5-trihydroxybenzoate)
- (2R)-3,4-Dihydro-2alpha-(3,4,5-trihydroxyphenyl)-3alpha-(3,4,5-trihydroxybenzoyloxy)-2H-1-benzopyran-5,7-diol
- (2R)-3,4-Dihydro-2alpha-(3,4,5-trihydroxyphenyl)-3alpha-[(galloyl)oxy]-2H-1-benzopyran-5,7-diol
- (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
- (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2H-1-benzopyran-5,7-diol
- (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate
- (2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate
- [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate
- 2041570-28-7
- 3,4,5-Trihydroxybenzoic acid (2R)-2alpha-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3alpha-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R)-2alpha-(3,4,5-trihydroxyphenyl)-5,7-dihydroxychroman-3alpha-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R)-3,4-dihydro-5,7-dihydroxy-2alpha-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3alpha-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R)-5,7-dihydroxy-2alpha-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3alpha-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R,3R)-2,3-dihydro-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-3-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester
- 3,4,5-Trihydroxybenzoic acid (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl ester
- 3,4,5-Trihydroxybenzoic acid [(2R,3R)-3,4-dihydro-5,7-dihydroxy-2alpha-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3alpha-yl] ester
- 3,4,5-Trihydroxybenzoic acid 2alpha-(3,4,5-trihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3alpha-yl ester
- 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate
- 84650-60-2
- 98902-20-6
- Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; Epigallocatechol, 3-gallate (7CI); Epigallocatechol, 3-gallate, (-)- (8CI); Epigallocatechol, gallate (6CI); Gallic acid, 3-ester with epigallocatechol, (-)- (8CI); (-)-Epigallocatechin 3-O-gallate; (-)-Epigallocatechin 3-gallate; (-)-Epigallocatechin gallate; (-)-Epigallocatechol gallate; (-)-epi-Gallocatechin 3-O-gallate; 3-O-Galloyl-(-)-epigallocatechin; EGCG; Epigallocatechin 3-O-gallate; Epigallocatechin 3-gallate; Epigallocatechin gallate; Epigallocatechin-3-monogallate; L-Epigallocatechin gallate; NVP-XAA 723; PF-EGCg 90; Teavigo; Theliokeep; epi-Gallocatechin 3-O-gallate; epi-Gallocatechin gallate
- Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-
- Gallic acid 2alpha-(3,4,5-trihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3alpha-yl ester
- KDH